Master switch found to stop tumor cell growth by inducing dormancy

Two existing cancer drugs turn on a gene that tells tumor cells to remain inactive, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published today in Nature Communications . Researchers discovered that the gene NR2F1, when switched on, programs tumor cells to stay dormant.

http://ift.tt/1z5St55